Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial

Cited by (1,000)

Items 101–200 of 1,000

1. A critical review on environmental presence of pharmaceutical drugs tested for the covid-19 treatment
   Ramiro Picoli Nippes, Paula Derksen Macruz, Gabriela Nascimento da Silva, Mara Heloísa Neves Olsen Scaliante · 2021 · Process Safety and Environmental Protection
2. COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2
   ANDRI ANDREOU, Sofia Trantza, Demetrios Filippou, Nikolaos V. Sipsas, Sotirios Tsiodras · 2020 · In Vivo
3. Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19
   Zi‐Ning Lei, Zhuo‐Xun Wu, Shaowei Dong, Dong‐Hua Yang, Litu Zhang, Zunfu Ke, Chang Zou, Zhe‐Sheng Chen · 2020 · Pharmacology & Therapeutics
4. Repurposing Quaternary Ammonium Compounds as Potential Treatments for COVID-19
   Nancy Baker, Antony John Williams, Alexander Tropsha, Sean Ekins · 2020 · Pharmaceutical Research
5. Tackling the cytokine storm in COVID-19, challenges and hopes
   Shifaa M. Abdin, Sara M. Elgendy, Shatha K. Alyammahi, Dima W. Alhamad, Hany A. Omar · 2020 · Life Sciences
6. A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment
   Ramy Mohamed Ghazy, Abdallah Mostafa Almaghraby, Ramy Shaaban, Ahmed Kamal, Hatem Beshir, Amr Moursi, Ahmed Ramadan, Sarah Hamed N. Taha · 2020 · Scientific Reports
7. Current Strategies of Antiviral Drug Discovery for COVID-19
   Miao Mei, Xu Tan · 2021 · Frontiers in Molecular Biosciences
8. Management of Heart Failure Patients with COVID-19: A Joint Position Paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology
   Yuhui Zhang, Andrew J.S. Coats, Zhe Zheng, Marianna Adamo, Giuseppe Ambrosio, Stefan D. Anker, Javed Butler, Dingli Xu, Jingyuan Mao, Muhammad Shahzeb Khan et al. · 2020 · European Journal of Heart Failure
9. Antimicrobial Photodynamic Therapy in the Control of COVID-19
   Adelaide Almeida, M. Amparo F. Faustino, Maria G. P. M. S. Neves · 2020 · Antibiotics
10. Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2
    Kathleen Chiotos, Molly Hayes, David Winston Kimberlin, Sarah B Jones, Scott H. James, Swetha Geetha Pinninti, April H. Yarbrough, Mark J. Abzug, Christine E. MacBrayne, Vijaya L Soma et al. · 2020 · Journal of the Pediatric Infectious Diseases Society
11. Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes
    Mina Thabet Kelleni · 2020 · Biomedicine & Pharmacotherapy
12. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19
    Giulia Fiscon, Federica Conte, Lorenzo Farina, Paola Paci · 2021 · PLoS Computational Biology
13. Cardiac arrhythmias in patients with COVID‐19
    Yueying Wang, Zhaojia Wang, Gary Tse, Lin Zhang, Elaine Y. Wan, Yutao Guo, Gregory Y.H. Lip, Guangping Li, Zhibing Lu, Tong Liu · 2020 · Journal of Arrhythmia
14. Clinical trials for COVID-19 should include sex as a variable
    Evelyne Yehudit Bischof, Jeannette Wolfe, Sabra L. Klein · 2020 · Journal of Clinical Investigation
15. Potential drug targets of SARS-CoV-2: From genomics to therapeutics
    Anas Shamsi, Taj Mohammad, Saleha Anwar, Samreen Amani, Mohd Shahnawaz Khan, Fohad Mabood Husain, Md Tabish Rehman, Asimul Islam, Md. Imtaiyaz Hassan · 2021 · International Journal of Biological Macromolecules
16. Withania somnifera (L.) Dunal: Opportunity for Clinical Repurposing in COVID-19 Management
    Akash Saggam, Kirti Limgaokar, Swapnil Borse, Preeti Chavan, Santosh Dixit, Girish Shrikrishna Tillu, Bhushan Patwardhan · 2021 · Frontiers in Pharmacology
17. Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: a report of consecutive cases from a New York City transplant center
    Michelle Lubetzky, Meredith J. Aull, Rebecca Craig‐Schapiro, John R. Lee, Jehona Marku‐Podvorica, Thalia Salinas, Laura F. Gingras, Jun B. Lee, Samuel T. Sultan, Rosy Priya Kodiyanplakkal et al. · 2020 · Nephrology Dialysis Transplantation
18. Estatística Cardiovascular – Brasil 2023
    Gláucia Maria Moraes de Oliveira, Luísa Campos Caldeira Brant, Carísi Anne Polanczyk, Déborah Carvalho Malta, Andréia Biolo, Bruno Ramos Nascimento, Maria de Fátima Marinho de Souza, Andrea De Lorenzo, Antônio Aurélio de Paiva Fagundes, Beatriz D'Agord Schaan et al. · 2024 · Arquivos Brasileiros de Cardiologia
19. Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19
    Jilei Zhang, Shari Garrett, Jun Sun · 2020 · Genes and Diseases
20. Application of Nanotechnology in the COVID-19 Pandemic
    Dongki Yang · 2021 · International Journal of Nanomedicine
21. The liver in times of COVID-19: What hepatologists should know
    Ezequiel Ridruejo, Alejandro Soza · 2020 · Annals of Hepatology
22. Emerging pharmacological therapies for ARDS: COVID-19 and beyond
    Shahd Horie, Bairbre McNicholas, Emanuele Rezoagli, Tài Olivier Pham, Ger Curley, Daniel Francis McAuley, Cecilia M. O’Kane, Alistair Nichol, Claúdia C. dos Santos, Patrícia R. M. Rocco et al. · 2020 · Intensive Care Medicine
23. COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness
    Fenghe Du, Bao Liu, Shuyang Zhang · 2020 · Journal of Thrombosis and Thrombolysis
24. Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort)
    Pablo Guisado‐Vasco, Sofia Valderas-Ortega, María Maravillas Carralón-González, Ana Roda Santacruz, Lucía González‐Cortijo, Gabriel Sotres-Fernández, Eva María Martí-Ballesteros, José Manuel Luque-Pinilla, Elena Almagro, Félix Lacoma Lanuza et al. · 2020 · EClinicalMedicine
25. Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines
    Xinni Xu, Yew Kwang Ong, De Yun Wang · 2020 · Military Medical Research
26. Genetic susceptibility for COVID-19–associated sudden cardiac death in African Americans
    John R. Giudicessi, Dan M. Roden, Arthur A.M. Wilde, Michael John Ackerman · 2020 · Heart Rhythm
27. SARS‐CoV ‐2 infection in people living with HIV : a systematic review
    Paola Costenaro, Chiara Minotti, Elisa Barbieri, Carlo Giaquinto, Daniele Donà · 2020 · Reviews in Medical Virology
28. Clinical Characteristics, Treatment, and Outcomes of Critically Ill Patients With COVID-19: A Scoping Review
    Chanyan Huang, Jalal Soleimani, Svetlana Herasevich, Yuliya Pinevich, Kelly M. Pennington, Yue Dong, Brian W. Pickering, Amelia K. Barwise · 2020 · Mayo Clinic Proceedings
29. An Updated Systematic Review of the Therapeutic Role of Hydroxychloroquine in Coronavirus Disease-19 (COVID-19)
    Saibal Das, Subhrojyoti Bhowmick, Sayali Tiwari, Sukanta Sen · 2020 · Clinical Drug Investigation
30. Acute chloroquine and hydroxychloroquine toxicity: A review for emergency clinicians
    Alessandra Della Porta, Kasha Bornstein, Austin Coye, Tim Montrief, Brit Long, Mehruba Anwar Parris · 2020 · The American Journal of Emergency Medicine
31. Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: A population-based study in the first two months of COVID-19 outbreak in Italy
    Luca Quartuccio, Francesca Valent, Enrico Pasut, Carlo Tascini, Salvatore De Vita · 2020 · Joint Bone Spine
32. The efficiency and safety of high-dose vitamin C in patients with COVID-19: a retrospective cohort study
    Dengfeng Gao, Min Xu, Gang Wang, Jianrui Lv, Xiaorong Ma, Yonghong Guo, Dexin Zhang, Huiyun Yang, Wei Jiang, Fuxue Deng et al. · 2021 · Aging
33. An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
    Omkar Indari, Shweta Jakhmola, Elangovan Manivannan, Hem Chandra Jha · 2021 · Frontiers in Pharmacology
34. Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
    Sophie Juul, Emil Eik Nielsen, Joshua Buron Feinberg, Faiza Siddiqui, Caroline Barkholt Kamp, Emily Barot, Niklas Nielsen, Peter Bentzer, Areti Angeliki Veroniki, Lehana Thabane et al. · 2020 · PLoS Medicine
35. Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies
    Praveen Mathews Varghese, Anthony George Tsolaki, Hadida Yasmin, Abhishek Shastri, Janez Ferluga, Manu Vatish, Taruna Madan, Uday Kishore · 2020 · Immunobiology
36. Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes
    Seong Woo Choi, Jin Soo Shin, Soon‐Jung Park, Eunhye Jung, Yun-Gwi Park, Jiho Lee, Sung Joon Kim, Hun‐Jun Park, Jung‐Hoon Lee, Sung‐Min Park et al. · 2020 · Antiviral Research
37. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients
    Sara Al‐Khawaga, Essam Mohamed Abdelalim · 2020 · Stem Cell Research & Therapy
38. A systematic review assessing the under-representation of elderly adults in COVID-19 trials
    on behalf of ESCMID Study Group for Infections in the Elderly (ESGIE), Virginie Prendki, Noam Tau, Tomer Avni, Marco Falcone, Angela Csaki Huttner, Laurent Kaiser, Mical Paul, Yaara Leibovici Weissman, Dafna Yahav · 2020 · BMC Geriatrics
39. Drug repurposing against COVID-19: focus on anticancer agents
    G. Ciliberto, R. Mancini, M. G. Paggi · 2020 · Journal of experimental & clinical cancer research : CR
40. Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic.
    John G. Rizk, Donald N. Forthal, Kamyar Kalantar‐Zadeh, Mandeep R. Mehra, Carl J. Lavie, Youssef Rizk, JoAnn P. Pfeiffer, John C. Lewin · 2020 · Drug Discovery Today
41. Artificial intelligence, drug repurposing and peer review
    Levin, Jeremy M., Oprea, Tudor I., Davidovich, Sagie, Clozel, Thomas, Overington, John P., Vanhaelen, Quentin, Cantor, Charles R., Bischof, Evelyne, Zhavoronkov, Alex · 2020 · Nature Biotechnology
42. Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?
    Sebastián Ibañez, Oriela Martínez, Francisca Valenzuela, Francisco Silva, Omar Valenzuela L · 2020 · Clinical Rheumatology
43. Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19
    Andrea Cortegiani, Mariachiara Ippolito, Giulia Ingoglia, Pasquale Iozzo, Antonino Giarratano, Sharon Einav · 2020 · Journal of Critical Care
44. A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19)
    Cheng‐Pin Chen, Yi‐Chun Lin, Tsung‐Chia Chen, Ting-Yu Tseng, Hon-Lai Wong, Cheng-Yu Kuo, Wu-Pu Lin, Sz-Rung Huang, Wei‐Yao Wang, Jia-Hung Liao et al. · 2020 · PLoS ONE
45. Targeting SARS-CoV-2 receptors as a means for reducing infectivity and improving antiviral and immune response: an algorithm-based method for overcoming resistance to antiviral agents
    Ram Gelman, Areej Bayatra, Asa Kessler, Asaf Schwartz, Yaron Ilan · 2020 · Emerging Microbes & Infections
46. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks
    Denise J. Wooding, Horacio Bach · 2020 · Clinical Microbiology and Infection
47. High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry
    Cláudia Diniz Lopes Marques, Adriana María Kakehasi, Marcelo Medeiros Pinheiro, Lícia Maria Henrique da Mota, Cleandro Pires de Albuquerque, Carolina Rocha Silva, Gabriela P. J. Santos, Edgard Torres dos Reis-Neto, Pedro Matos, Guilherme Devidé et al. · 2021 · RMD Open
48. COVID-19 Therapeutic Options Under Investigation
    Malak Kaddoura, Malak Al Ibrahim, Ghina Hijazi, Nadia Soudani, Amani Audi, Habib Alkalamouni, Salame Haddad, Ali Hussein Eid, Hassan Zaraket · 2020 · Frontiers in Pharmacology
49. COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs
    Alessandra Bartoli, Filippo Gabrielli, Tatiana Alicandro, Fabio Nascimbeni, Pietro Andreoné · 2021 · Internal and Emergency Medicine
50. SAveRUNNER: an R-based tool for drug repurposing
    Giulia Fiscon, Paola Paci · 2021 · BMC Bioinformatics
51. Effectiveness of Natural Antioxidants against SARS-CoV-2? Insights from the In-Silico World
    Muhammad Fayyaz ur Rehman, Shahzaib Akhter, Aima Iram Batool, Zeliha Selamoğlu, Мustafa Sevindik, Rida Eman, Muhammad Mustaqeem, Muhammad Safwan Akram, Fariha Kanwal, Changrui Lu et al. · 2021 · Antibiotics
52. Giardiasis treatment: an update with a focus on refractory disease
    Kristine Mørch, Kurt Hanevik · 2020 · Current Opinion in Infectious Diseases
53. Hydroxychloroquine Controversies: Clinical Trials, Epistemology, and the Democratization of Science
    Luc Berlivet, Ilana Löwy · 2020 · Medical Anthropology Quarterly
54. S2k-Leitlinie – Empfehlungen zur stationären Therapie von Patienten mit COVID-19
    Stefan Kluge, Uwe Janssens, Tobias Welte, Steffen Weber‐Carstens, Gereon Schälte, Christoph D. Spinner, Jakob J Malin, Petra Gastmeier, Florian Peter Länger, Martin Wepler et al. · 2021 · Pneumologie
55. Cardiac effects and toxicity of chloroquine: a short update
    Kanigula Mubagwa · 2020 · International Journal of Antimicrobial Agents
56. Antirheumatic Disease Therapies for the Treatment of COVID‐19: A Systematic Review and Meta‐Analysis
    Michael Putman, Yu Pei Eugenia Chock, Herman H. Y. Tam, Alfred H.J. Kim, Sebastian Eduardo Sattui, Françis Berenbaum, Maria I. Danila, Peter Korsten, Catalina Sánchez-Álvarez, Jeffrey A. Sparks et al. · 2020 · Arthritis & Rheumatology
57. Developing a sustainable exit strategy for COVID-19: health, economic and public policy implications
    Michael Anderson, Martin McKee, Elias A. Mossialos · 2020 · Journal of the Royal Society of Medicine
58. SARS-CoV-2 disease severity and diabetes: why the connection and what is to be done?
    Caio Henrique Mazucanti, Josephine Mary Egan · 2020 · Immunity & Ageing
59. COVID-19 cardiovascular epidemiology, cellular pathogenesis, clinical manifestations and management
    Yasar Sattar, Waqas Ullah, Hiba Rauf, Hafeez Ul Hassan Virk, Sunita Kumari Yadav, Medhat Chowdhury, Michael A. Connerney, Sahil S Mamtani, Mohit Pahuja, Raj Patel et al. · 2020 · IJC Heart & Vasculature
60. An overview on the treatments and prevention against COVID-19
    Yunes Panahi, Armita Mahdavi Gorabi, Sona Talaei, Fatemeh Beiraghdar, Abolfazl Akbarzadeh, Vahideh Tarhriz, Hassan Mellatyar · 2023 · Virology Journal
61. COVID-19 in elderly kidney transplant recipients
    Marta Crespo, María José Pérez‐Sáez, Dolores Redondo‐Pachón, Laura Llinàs-Mallol, M. Montero, Judith Villar, Carlos Arias-Cabrales, Anna Buxeda, Carla Burballa, Susana Vázquez González et al. · 2020 · American Journal of Transplantation
62. Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world
    Matthieu Million, Philippe Gautret, Philippe Colson, Yanis Roussel, G. Dubourg, Éric Chabrière, Stéphane Honoré, Jean‐Marc Rolain, Florence Fenollar, Pierre‐Edouard Fournier et al. · 2020 · New Microbes and New Infections
63. Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19
    Sebastian Eduardo Sattui, Jean W. Liew, Elizabeth R. Graef, Ariella L. G. Coler-Reilly, Françis Berenbaum, Alí Duarte‐García, Carly Harrison, Maximilian F. Konig, Peter Korsten, Michael Putman et al. · 2020 · Expert Review of Clinical Immunology
64. Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus
    Calvin Andeve Omolo, Nikki Soni, Victoria Oluwaseun Fasiku, Irene Mackraj, Thirumala Govender · 2020 · European Journal of Pharmacology
65. Antiviral therapies: advances and perspectives
    Bruna Carolina Gonçalves, Mário Gabriel Lopes Barboza, Anna Paula Silva Olak, Natalia Belebecha Terezo, Letícia Nishi, Maria Angélica Ehara Watanabe, Poliana Camila Marinello, Daniele Zendrini Rechenchoski, Sérgio Paulo Dejato Rocha, Ligia Carla Faccin Galhardi · 2020 · Fundamental and Clinical Pharmacology
66. SARS-CoV-2 ORF3a induces RETREG1/FAM134B-dependent reticulophagy and triggers sequential ER stress and inflammatory responses during SARS-CoV-2 infection
    Xiaolin Zhang, Ziwei Yang, Ting Shuang Pan, Xubing Long, Qinqin Sun, Pei‐Hui Wang, Xiaojuan Li, Ersheng Kuang · 2022 · Autophagy
67. COVID‐19 and immunological regulations – from basic and translational aspects to clinical implications
    Michael Peter Schön, Carola Berking, Tilo Biedermann, Timo Buhl, Luise Erpenbeck, Kilian Eyerich, Stefanie Eyerich, Kamran Ghoreschi, Matthias Goebeler, Ralf Joachim Ludwig et al. · 2020 · JDDG Journal der Deutschen Dermatologischen Gesellschaft
68. Heterocyclic compounds as antiviral drugs: Synthesis, structure–activity relationship and traditional applications
    Giovanny Carvalho dos Santos, Lucas Michelão Martins, Bruna Andressa Bregadiolli, Vitor Fernandes Moreno, Luiz Carlos da Silva‐Filho, Bruno Silva · 2021 · Journal of Heterocyclic Chemistry
69. Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine
    Srinivasa Reddy Bonam, Sylviane Muller, Jagadeesh Bayry, Daniel J. Klionsky · 2020 · Autophagy
70. Availability and price changes of potential medicines and equipment for the prevention and treatment of COVID-19 among pharmacy and drug stores in Bangladesh; findings and implications
    M. Haque, Salequl Islam, S. Iqbal, U. Urmi, Z. Kamal, Aminur Rahman, M. Kamal, M. Haque, Iffat Jahan, Zakirul Islam et al. · 2020 · Bangladesh Journal of Medical Science
71. COVID-19: An overview of the current pharmacological interventions, vaccines, and clinical trials
    Rohan Chakraborty, Suhel Parvez · 2020 · Biochemical Pharmacology
72. Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review
    Sultan Ayesh Mohammed Saghir, Naif Ahmed Al-Gabri, Mahmoud M. Alagawany, Youssef A. Attia, Salem Rashed Alyileili, Shaaban Saad Elnesr, Manal Esam Shafi, Omar Alshargi, Nader Al-balagi, Abdullah Saleh Al-wajeeh et al. · 2021 · Therapeutics and Clinical Risk Management
73. Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.
    Vinicius Fontanesi Blum, Sérgio Cimerman, James Hunter, Paulo Fernando Guimarães Morando Marzocchi Tierno, Acioly L.T. Lacerda, Alexandre de Matos Soeiro, Florentino Cardoso, Nancy Bellei, Juliana Terzi Maricato, Nathalia Mantovani et al. · 2021 · EClinicalMedicine
74. Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management (Pilot Trial)
    Faiq I. Gorial, Sabeeh A. Al Mashhadani, Hend M. Sayaly, Basim Dhawi Dakhil, Marwan AlMashhadani, Adnan M Al-jabory, Hassan Mohammed Abbas, Mohammed Ghanim, Jawad Ibrahim Rasheed · 2020 · medRxiv
75. An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics
    Dongyuan Wang, Zigang Li, Yihui Liu · 2020 · Journal of Infection and Public Health
76. Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients
    Alpana Waghmare, Maheen Z. Abidi, Michael Boeckh, Roy F. Chemaly, Sanjeet Dadwal, Zeinab El Boghdadly, Mini Kamboj, Genovefa A. Papanicolaou, Steven A. Pergam, Zainab Shahid · 2020 · Transplantation and Cellular Therapy
77. Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2
    Hanjun Zhao, Kelvin Kai‐Wang To, Hoiyan Lam, Xinxin Zhou, Jasper Fuk‐Woo Chan, Zheng Peng, Andrew Chak-Yiu Lee, Jian‐Piao Cai, Wan-Mui Chan, Jonathan Daniel Ip et al. · 2021 · Nature Communications
78. Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China
    Xiaoqi Pan, Lan Dong, Lian Yang, Dayi Chen, Cheng Yun Peng · 2020 · Virus Research
79. Cardiac Toxicity of Chloroquine or Hydroxychloroquine in Patients With COVID-19: A Systematic Review and Meta-regression Analysis
    Imad M. Tleyjeh, Zakariya Kashour, Oweida AlDosary, Muhammad Ali Riaz, Haytham Tlayjeh, Musa Abubakar Garbati, Rana Tleyjeh, Mouaz Husayn Al-Mallah, Muhammad Rizwan Sohail, Dana Gerberi et al. · 2020 · Mayo Clinic Proceedings Innovations Quality & Outcomes
80. The Danger of Misinformation in the COVID-19 Crisis.
    Taylor Nelson, Nicole Kagan, Claire Critchlow, Alan E. Hillard, Albert L. Hsu · 2020 · PubMed Central
81. Molecular mechanisms and epidemiology of COVID-19 from an allergist’s perspective
    Hosoki, Koa, Chakraborty, Abhijit, Sur, Sanjiv · 2020 · Journal of Allergy and Clinical Immunology
82. A systematic review of ECG findings in patients with COVID-19
    Esmaeil Mehraeen, SeyedAhmad SeyedAlinaghi, Ali A. Nowroozi, Omid Dadras, Sanam Alilou, Parnian Shobeiri, Farzane Behnezhad, Amirali Karimi · 2020 · Indian Heart Journal
83. Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy
    Mona Sadat Mirtaleb, Amir Hossein Mirtaleb, Hassan Nosrati, Jalal Heshmatnia, Reza Falak, Reza Zolfaghari Emameh · 2021 · Biomedicine & Pharmacotherapy
84. Targeting the NO‐cGMP‐PDE5 pathway in COVID‐19 infection. The DEDALO project
    Andrea Maria Isidori, Elisa Giannetta, Riccardo Pofi, Mary Anna Venneri, Daniele Gianfrilli, Federica Campolo, Claudio Maria Mastroianni, Andrea Lenzi, Gabriella d’Ettorre · 2020 · Andrology
85. Current treatment in COVID-19 disease: a rapid review
    Miguel Antonio Rodriguez Guerra, Preeti Jadhav, Timothy J. Vittorio · 2021 · Drugs in Context
86. Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials
    Rami A. Al‐Horani, Srabani Kar, Kholoud F. Aliter · 2020 · International Journal of Molecular Sciences
87. Analysis of Scientific Publications During the Early Phase of the COVID-19 Pandemic: Topic Modeling Study
    Andreas Älgå, Oskar Eriksson, M. E. Nordberg · 2020 · Journal of Medical Internet Research
88. Drug-drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review
    Beatriz Oda Plasencia-García, Gonzalo Rodríguez-Menéndez, María Isabel Rico-Rangel, Ana Rubio-García, Jaime Torelló-Iserte, Benedicto Crespo‐Facorro · 2021 · Psychopharmacology
89. Amantadine Treatment for People with COVID-19
    Ramiro Araújo, José Dolores Aranda‐Martínez, Gonzálo Emiliano Aranda-Abreu · 2020 · Archives of Medical Research
90. Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome
    Rodrigo Cerqueira Borges, Miriam Sayuri Hohmann, Sérgio M. Borghi · 2020 · International Reviews of Immunology
91. O uso político da cloroquina: COVID-19, negacionismo e neoliberalismo / The political use of chloroquine: COVID-19, denialism and neoliberalism
    Sandra Noemi Caponi, Fabíola Stolf Brzozowski, Fernando Hellmann, Sílvia Cardoso Bittencourt · 2021 · Revista Brasileira de Sociologia - RBS
92. Transcriptome analysis of cepharanthine against a SARS-CoV-2-related coronavirus
    Shasha Li, Wenli Liu, Yangzhen Chen, Liqin Wang, Wenlin An, Xiaoping An, Lihua Song, Yigang Tong, Huahao Fan, Chenyang Lu · 2020 · Briefings in Bioinformatics
93. Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
    Sophie Juul, Emil Eik Nielsen, Joshua Buron Feinberg, Faiza Siddiqui, Caroline Barkholt Kamp, Emily Barot, Johan Holgersson, Niklas Nielsen, Peter Bentzer, Areti Angeliki Veroniki et al. · 2021 · PLoS ONE
94. Photocatalytic degradation of hydroxychloroquine using ZnO supported on clinoptilolite zeolite
    Patricia Lacchi da Silva, Ramiro Picoli Nippes, Paula Derksen Macruz, Fábio Luís Hegeto, Mara Heloísa Neves Olsen Scaliante · 2021 · Water Science & Technology
95. Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study
    Shoya Iwanami, Keisuke Ejima, Kwang Su Kim, Koji Noshita, Yasuhisa Fujita, Taiga Miyazaki, Shigeru Kohno, Yoshitsugu Miyazaki, Shimpei Morimoto, Shinji Nakaoka et al. · 2021 · PLoS Medicine
96. Human organ chip-enabled pipeline to rapidly repurpose therapeutics during viral pandemics
    Longlong Si, Haiqing Bai, Melissa J. Rodas, Wuji Cao, Crystal Yuri Oh, Amanda R. Jiang, Rasmus Møller, Daisy A. Hoagland, Kohei Oishi, Shu Horiuchi et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
97. Opportunities for biomaterials to address the challenges of COVID ‐19
    Daniel Chakhalian, Robert B. Shultz, Catherine E. Miles, Joachim Kohn · 2020 · Journal of Biomedical Materials Research Part A
98. Emerging Therapeutic Approaches to Combat COVID-19: Present Status and Future Perspectives
    Karthik Vivekanandhan, Shanmugam Poornima, Hamed Barabadi, Vigneshwaran Arumugam, Dharun Daniel Raj Daniel Paul Raj, Sivasubramanian Manikandan, Ramasamy Subbaiya, Krishnan Anand, Boomi Pandi, Balakumar Chandrasekaran et al. · 2021 · Frontiers in Molecular Biosciences
99. How Brazil’s President turned the country into a global epicenter of COVID-19
    Lucas Ferrante, Luiz Henrique Duczmal, Wilhelm Alexander Cardoso Steinmetz, Alexandre C. L. Almeida, Jeremias Leão, Ruth Camargo Vassão, Unaí Tupinambás, Philip M. Fearnside · 2021 · Journal of Public Health Policy
100. Covid-19 treatment update: follow the scientific evidence
     Richard Clinton Becker · 2020 · Journal of Thrombosis and Thrombolysis